Pediatric Blood & Cancer

Cover image for Pediatric Blood & Cancer

January 2004

Volume 42, Issue 1

Pages 1–112

  1. Editorial

    1. Top of page
    2. Editorial
    3. Commentary
    4. Research Articles
    1. Editorial (pages 1–2)

      Beverly Lange and Alan Craft

      Version of Record online: 25 NOV 2003 | DOI: 10.1002/pbc.10478

  2. Commentary

    1. Top of page
    2. Editorial
    3. Commentary
    4. Research Articles
    1. Recent report in the etiology of childhood cancer: ‘Greatest Hits’ (pages 3–7)

      Julie A. Ross and Stella M. Davies

      Version of Record online: 25 NOV 2003 | DOI: 10.1002/pbc.10465

  3. Research Articles

    1. Top of page
    2. Editorial
    3. Commentary
    4. Research Articles
    1. Outcome of children with high-risk acute lymphoblastic leukemia (HR-ALL): Nordic results on an intensive regimen with restricted central nervous system irradiation (pages 8–23)

      Ulla M. Saarinen-Pihkala, G. Gustafsson, N. Carlsen, T. Flaegstad, E. Forestier, A. Glomstein, J. Kristinsson, M. Lanning, H. Schroeder and L. Mellander

      Version of Record online: 5 NOV 2003 | DOI: 10.1002/pbc.10461

    2. CNS-directed therapy in young children with T-lineage acute lymphoblastic leukemia: High-dose methotrexate versus cranial irradiation (pages 24–29)

      Paul C. Nathan, Ronnen Maze, Brenda Spiegler, Mark L. Greenberg, Sheila Weitzman and Johann K. Hitzler

      Version of Record online: 30 OCT 2003 | DOI: 10.1002/pbc.10392

    3. Favorable outcome in 20-year follow-up of children with very-low-risk ALL and minimal standard therapy, with special reference to TELAML1 fusion (pages 30–35)

      Jukka Kanerva, Ulla M. Saarinen-Pihkala, Tarja Niini, Pekka Riikonen, Merja Möttönen, Anne Mäkipernaa, Toivo T. Salmi, Kim Vettenranta and Sakari Knuutila

      Version of Record online: 29 OCT 2003 | DOI: 10.1002/pbc.10417

    4. Immune responses to influenza immunization in children receiving maintenance chemotherapy for acute lymphoblastic leukemia (pages 36–40)

      Christopher C. Porter, Kathryn M. Edwards, Yuwei Zhu and Haydar Frangoul

      Version of Record online: 5 NOV 2003 | DOI: 10.1002/pbc.10459

    5. An examination of outcome measures to assess functional mobility in childhood survivors of osteosarcoma (pages 41–45)

      Victoria G. Marchese, Susan Ogle, Richard B. Womer, John Dormans and Jill P. Ginsberg

      Version of Record online: 7 NOV 2003 | DOI: 10.1002/pbc.10462

    6. The patterns of relapse in osteosarcoma: The memorial Sloan-Kettering experience (pages 46–51)

      Susan N. Chi, Laurie S. Conklin, Jing Qin, Paul A. Meyers, Andrew G. Huvos, John H. Healey and Richard Gorlick

      Version of Record online: 30 OCT 2003 | DOI: 10.1002/pbc.10420

    7. Methotrexate pharmacokinetics and survival in osteosarcoma (pages 52–58)

      Irene Aquerreta, Azucena Aldaz, Joaquín Giráldez and Luis Sierrasesúmaga

      Version of Record online: 29 OCT 2003 | DOI: 10.1002/pbc.10443

    8. Stature of young people with malignant bone tumors (pages 59–63)

      Simon J. Cotterill, Charlotte M. Wright, Mark S. Pearce and Alan W. Craft

      Version of Record online: 29 OCT 2003 | DOI: 10.1002/pbc.10437

    9. Liver transplantation for hepatoblastoma: Results from the International Society of Pediatric Oncology (SIOP) study SIOPEL-1 and review of the world experience (pages 74–83)

      J.B. Otte, J. Pritchard, D.C. Aronson, J. Brown, P. Czauderna, R. Maibach, G. Perilongo, E. Shafford and J. Plaschkes

      Version of Record online: 25 NOV 2003 | DOI: 10.1002/pbc.10376

    10. A prospective study of thyroid nodular disease in children and adolescents in western Poland from 1996 to 2000 and the incidence of thyroid carcinoma relative to iodine deficiency and the Chernobyl disaster (pages 84–92)

      Marek Niedziela, Eugeniusz Korman, Danuta Breborowicz, Ewa Trejster, Jerzy Harasymczuk, Malgorzata Warzywoda, Michal Rolski and Jan Breborowicz

      Version of Record online: 25 NOV 2003 | DOI: 10.1002/pbc.10421

    11. Phase I study of oral cyclophosphamide and oral topotecan for children with recurrent or refractory solid tumors (pages 93–98)

      Daniel C. Bowers, Victor M. Aquino, Patrick J. Leavey, Robert O. Bash, Janna M. Journeycake, Gail Tomlinson, Arlynn F. Mulne, Heidi J. Haynes and Naomi J. Winick

      Version of Record online: 5 NOV 2003 | DOI: 10.1002/pbc.10456

    12. Genetic epidemiology of neuroblastoma: A study of 426 cases at the Institut Gustave-Roussy in France (pages 99–105)

      Taraneh Shojaei-Brosseau, Agnès Chompret, Anne Abel, Florent de Vathaire, Marie-Anne Raquin, Laurence Brugières, Jean Feunteun, Olivier Hartmann and Catherine Bonaïti-Pellié

      Version of Record online: 30 OCT 2003 | DOI: 10.1002/pbc.10381

    13. Non-conventional therapies in childhood cancer: Guidelines for distinguishing non-harmful from harmful therapies: A report of the SIOP Working Committee on Psychosocial Issues in Pediatric Oncology (pages 106–108)

      Momcilo Jankovic, John J. Spinetta, Antonio Gentil Martins, Andrea Pession, Michael Sullivan, Giulio J. D'Angio, Tim Eden, Myriam Weyl Ben Arush, Sutaryo X, Leena-Riitta Punkko, Claudia Epelman and Giuseppe Masera

      Version of Record online: 29 OCT 2003 | DOI: 10.1002/pbc.10418

    14. Clinical features and treatment outcomes of 79 infants with immune thrombocytopenic purpura (pages 109–112)

      Claudio Sandoval, Paul Visintainer, M. Fevzi Ozkaynak, Oya Tugal and Somasundaram Jayabose

      Version of Record online: 5 NOV 2003 | DOI: 10.1002/pbc.10458

SEARCH

SEARCH BY CITATION